Skip to content

Brain Works

Facebook
Twitter
LinkedIn
Ariana Gatt talks about pharma, fruit fly research, and Alzheimer’s and Parkinson’s disease.
Ariana Gatt
Ariana Gatt

In 2008 I graduated from the University of Malta with a B.Sc. in Chemistry and Biology. Then, I worked as an R&D chemist with SoleaPharma Ltd., which also allowed me to spend six months training in pharmaceutical chemistry in Spain at the mother company Gadea Pharmaceuticals. I learned a lot in this period—not only lab work skills, but also about the whole business and industry. However, after two years working in the pharma industry, I realised I still wanted to further my studies.

I had always dreamed of studying abroad and experiencing a university in another country, so I applied for Masters courses in the UK. I had realised by this point that I wanted to carry out biomedical research, with a particular interest in neuroscience. I read for an M.Sc. in molecular sciences and biomedical research at King’s College London, funded by an EU funded STEPS scholarship. The M.Sc. opened the door for a Ph.D. in the same lab, which I am currently finishing .

For my Ph.D., I am investigating the role of mitochondrial dysfunction in neurodegeneration. Mitochondria produce energy for our cells. They are especially important in brain cells, since the brain uses 20% of the body’s energy. In neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, mitochondria stop functioning properly, leading to a loss of energy in the brain. This may contribute to the eventual death of brain cells. In my project, I am modelling the loss of mitochondrial function in fruit flies (Drosophila melanogaster) to understand the early stages of neurodegeneration. Fruit flies and humans share many genes and therefore, studying the genes involved in mitochondrial dysfunction in the fly allows us to find potential early treatments to prevent irreparable damage in human neurodegenerative diseases. 

Part of my Ph.D. focuses on studying human tissue from patients who have died from these diseases. These post-mortem tissue samples are obtained from UK brain banks. I am using them to identify genes that are involved in these diseases. 

I don’t know what lies ahead in my career path. I hope it will involve answering questions regarding brain function and helping to solve the many puzzles related to neurodegenerative disease. 

Author

More to Explore

URNA: Bonding Flame

URNA is Malta’s response to the 5th edition of the London Design Biennale 2025. THINK speaks to curator Andrew Borg Wirth and Arts Council Malta Internationalisation Executive Romina Delia to learn how this project seeks to create a connection between souls when experiencing a loss.

MaltaHip Project: When Ideas Become Reality

The earliest recorded attempts at hip replacement date back to 1891. At the time, ivory was proposed to replace the femoral heads of patients whose hip joints had been destroyed by tuberculosis. Since then, everything changed. THINK speaks to the MaltaHip Team to learn about their innovative hip replacement technology.

HUMS ‘The Sun’: Bridging the Sciences and Humanities in a Cross-Disciplinary Exploration

The Humanities, Medicine, and Science (HUMS) Symposia at the University of Malta offer a unique platform where experts from diverse fields come together to explore a single theme from multiple disciplinary perspectives. This academic year, the HUMS first event, entitled ‘The Sun’, provided an interdisciplinary deep dive into the scientific, cultural, and existential significance of our closest star.

Comments are closed for this article!